source
- Sanofi’s research focus may shift under new CEO Belén Garijo, amid gene therapy advances and telehealth debatesSanofi is entering a period of strategic reassessment as Belén Garijo assumes the chief executive role. Observers are watching to see whether the company will adjust its recent emphasis on immunolo…
- Amneal to acquire biosimilar maker for $375 million upfrontAmneal Pharmaceuticals announced it will purchase a biosimilar development company, agreeing to pay $375 million in an upfront cash payment. The deal expands Amneal’s portfolio in the growing biosi…